The NK-cell activating receptors, CD69 and NKG2D, were downregulated, and the suppression of EV biogenesis confirmed that tumor cell derived-EVs were responsible for the effect of saliva-derived EVs on peripheral NK cell dysfunction. The gene discussed is KLRK1; the disease is neoplasm.